|
|
| Rett Syndrome Sequencing | ||
| Order Code: RETTS
Order Form: A-1a Miscellaneous Request or IPR Req |
Commercial "Mail-out" Laboratory 6240 RCP 356-3527 |
|
Specimen |
Whole Blood | ||
Collection Medium: |
| ||
Alternate Collection Media: |
Lavender top tube (EDTA) | ||
Minimum: |
Adult minimum: Collect TWO 6 mL pink top (EDTA sprayed) tubes Child minimum: Collect one FULL 6 mL pink top (EDTA sprayed) tube Infant minimum: 2-4 mL whole blood from pink top (EDTA sprayed) tube Please contact the laboratory for specific requirements for prenatal testing. | ||
Analytic Time: |
3 weeks | ||
Comments: |
Please print, complete, and submit the following form with the appropriate signatures, the correct sample type and the A-1a Miscellaneous Request: Gene Sequencing (SEQ) Requisition from Bayler College of Medicine (BCM) Medical Genetics Laboratories. | ||
Test Limitations: |
Rett syndrome is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene which encodes the Methyl CpG Binding Protein 2 transcriptional repressor. Rett syndrome affects ~1 in 10,000 females with symptoms including loss of speech and purposeful hand use, microcephaly, seizures, ataxia, and stereotypic hand movements. MECP2 mutations manifest a broader spectrum of clinical phenotypes in female and rare male patients, with features overlapping with other mental retardation disorders. Mutations in the MECP2 coding region can be detected by sequence analysis in up to ~85% of Rett cases. Sequencing has an analytical sensitivity of ~99% for point mutations. Up to ~85% of classic Rett patients have MECP2 gene mutations that can be identified by sequencing. | ||
Methodology: |
DNA Sequencing of MECP2 exons 1 through 4 in both directions using a 96-capillary sequencer. | ||
CPT Code: |
83904x7, 83912, 83909x14, 83898x10, 83894, 83891 |
Updated: 04/23/2008
Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.